ArticleActa pharmacologica Sinica2022

Trilobatin rescues cognitive impairment of Alzheimer's disease by targeting HMGB1 through mediating SIRT3/SOD2 signaling pathway.

Jian-Mei Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.